Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
EQT exits Pioneer in $1.1bn sale to CarUX after five-year transformation
EQT exits Pioneer in $1.1bn sale to CarUX after five-year transformation EQT has agreed to sell Pioneer Corporation, its Japan-based automotive tech portfolio company, to CarUX for $1.1bn. CarUX, a smart cockpit solutions provider and subsidiary of Taiwan’s Innolux,...
JC Flowers-backed Jefferson Capital raises $150m in Nasdaq IPO, retains majority control
JC Flowers-backed Jefferson Capital raises $150m in Nasdaq IPO, retains majority control Jefferson Capital, a consumer debt specialist backed by JC Flowers & Co., has raised $150m in its Nasdaq debut, marking a significant milestone in the private equity firm’s...
Hg-backed Visma targets blockbuster IPO in London in €19bn tech listing
Hg-backed Visma targets blockbuster IPO in London in €19bn tech listing Private equity giant Hg is preparing to take portfolio company Visma public in London in early 2026, marking one of the UK’s most significant tech IPOs in years. The €19bn listing could provide a...